Literature DB >> 7747653

Inhibiting the effects of cytokines in human diseases.

W P Arend1.   

Abstract

In reviewing some of the mechanisms whereby cytokine effects are inhibited or blocked, this chapter has illustrated that the cytokine network is truly self-regulating. Exaggerated effects of particular cytokines in disease processes may be due to unregulated production of proinflammatory cytokines or inadequate production of anti-inflammatory cytokines. In addition, cytokine effects may be regulated at the levels of production, protein binding, receptor expression, soluble receptor generation, or receptor binding. Monoclonal antibodies to TNF-alpha, soluble receptors for IL-1 or TNF, and IL-1ra represent four promising approaches for therapeutic intervention in human diseases. As more knowledge is gained about the cytokine network in human diseases, additional avenues for treatment through inhibition of cytokine effects are certain to evolve.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7747653

Source DB:  PubMed          Journal:  Adv Intern Med        ISSN: 0065-2822


  5 in total

1.  Relations between surface expression of the interleukin-2 receptor and release of the soluble form of the receptor in cultured mononuclear cells from patients with rheumatoid arthritis or systemic lupus erythematosus.

Authors:  M Itoh; Y Goto; Y Ohta; Y Goto; H Ohashi
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

Review 2.  Cytokine regulation of epithelial permeability and ion transport.

Authors:  D M McKay; A W Baird
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

3.  The soluble tumor necrosis factor receptor I is an early predictor of local infective complications after colorectal surgery.

Authors:  Robert Slotwiński; Waldemar L Olszewski; Andrzej Chaber; Maciej Slodkowski; Marzanna Zaleska; Ireneusz W Krasnodebski
Journal:  J Clin Immunol       Date:  2002-09       Impact factor: 8.317

4.  Metabolism of Tac (IL2Ralpha): physiology of cell surface shedding and renal catabolism, and suppression of catabolism by antibody binding.

Authors:  R P Junghans; T A Waldmann
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

5.  Profile of soluble cytokine receptors in Crohn's disease.

Authors:  T Gustot; A Lemmers; E Louis; C Nicaise; E Quertinmont; J Belaiche; S Roland; A Van Gossum; J Devière; D Franchimont
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.